We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Better Class of Cancer Drugs

News   Sep 18, 2015

 
A Better Class of Cancer Drugs
 
 
Advertisement
 

RELATED ARTICLES

Genomic Profiling Tracks the Global Spread of Disease

News

Scientists in 18 countries have used genome sequencing technology to track the the global spread and exchange of Streptococcus equi, which causes the disease strangles, in the largest ever study of its kind.

READ MORE

Novel Inhibitor Shown To Combat Drug-Resistant Tumor Cells

News

A team of researchers from Martin Luther University Halle-Wittenberg and the University of Greifswald has developed a new inhibitor of multi-drug resistant protein 4 (MRP4). When the inhibitor was tested on drug-resistant cancer cell lines, the cancer cells began to respond to chemotherapy.

READ MORE

New Study Predicts SARS-CoV-2 Evolving To Escape Current Vaccines

News

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE